Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by DRDO in collaboration with Dr Reddy's Laboratories, Hyderabad: Defence ministry.


PTI | New Delhi | Updated: 08-05-2021 15:03 IST | Created: 08-05-2021 15:03 IST
Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by DRDO in collaboration with Dr Reddy's Laboratories, Hyderabad: Defence ministry.
  • Country:
  • India

Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by DRDO in collaboration with Dr Reddy's Laboratories, Hyderabad: Defence ministry.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback